Skip to main content
Top
Published in:

Open Access 01-12-2023 | Uveitis | Case Report

Acute uveitis caused by abnormal glucose and lipid metabolism: a case report

Authors: Zhaojing Bi, Yan Liang, Shujun Liu, Yuanbin Li

Published in: BMC Ophthalmology | Issue 1/2023

Login to get access

Abstract

Purpose

This report describes a rare case of acute uveitis with severe anterior chamber inflammation due to abnormal glucose and lipid metabolism.

Case presentation

A 31-year-old male patient complained of redness in the right eye with decreased visual acuity for 3 days. Ocular examination revealed a milky white clouding of the right anterior chamber of the eye. Two clusters of yellowish-white exudates were visible on the surface of the iris in the upper nasal and temporal areas in addition to elevated intraocular pressure. He had a previous diagnosis of type 2 diabetes mellitus (T2DM). Laboratory tests suggested hyperlipidemia and ketoacidosis. After admission, topical glucocorticoids, mydriasis, and intraocular pressure-lowering drugs combined with hypoglycemic and lipid-lowering therapy and fluid replacement therapy were given immediately. After 10 days of treatment, the uveitis and systemic condition of the right eye were effectively controlled and improved.

Conclusion

Abnormal glucose and lipid metabolism leads to impairment of the blood-aqueous barrier, which causes a severe uveitis response in the anterior chamber. After the use of topical steroids and mydriatic eye drops combined with systemic hypoglycemic and lipid-lowering interventions, the condition was significantly relieved.
Literature
2.
go back to reference Miserocchi E, et al. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013;23(5):705–17.CrossRefPubMed Miserocchi E, et al. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013;23(5):705–17.CrossRefPubMed
3.
go back to reference Ansari AS, et al. Glycemic control is an important modifiable risk factor for uveitis in patients with diabetes: a retrospective cohort study establishing clinical risk and ophthalmic disease burden. J Diabetes Complications. 2018;32(6):602–8.CrossRefPubMed Ansari AS, et al. Glycemic control is an important modifiable risk factor for uveitis in patients with diabetes: a retrospective cohort study establishing clinical risk and ophthalmic disease burden. J Diabetes Complications. 2018;32(6):602–8.CrossRefPubMed
4.
go back to reference Crispin S. Ocular lipid deposition and hyperlipoproteinaemia. Prog Retin Eye Res. 2002;21(2):169–224.CrossRefPubMed Crispin S. Ocular lipid deposition and hyperlipoproteinaemia. Prog Retin Eye Res. 2002;21(2):169–224.CrossRefPubMed
5.
go back to reference Vinger PF, Sachs BA. Ocular manifestations of hyperlipoproteinemia. Am J Ophthalmol. 1970;70(4):563–73.CrossRefPubMed Vinger PF, Sachs BA. Ocular manifestations of hyperlipoproteinemia. Am J Ophthalmol. 1970;70(4):563–73.CrossRefPubMed
6.
go back to reference Anderson RA, et al. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis. 2001;154(2):475–83.CrossRefPubMed Anderson RA, et al. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. Atherosclerosis. 2001;154(2):475–83.CrossRefPubMed
7.
go back to reference Sena CM, Pereira AM, Seica R. Endothelial dysfunction - a major mediator of diabetic vascular disease. Biochim Biophys Acta. 2013;1832(12):2216–31.CrossRefPubMed Sena CM, Pereira AM, Seica R. Endothelial dysfunction - a major mediator of diabetic vascular disease. Biochim Biophys Acta. 2013;1832(12):2216–31.CrossRefPubMed
8.
go back to reference Wallace JP, et al. Postprandial lipaemia, oxidative stress and endothelial function: a review. Int J Clin Pract. 2010;64(3):389–403.CrossRefPubMed Wallace JP, et al. Postprandial lipaemia, oxidative stress and endothelial function: a review. Int J Clin Pract. 2010;64(3):389–403.CrossRefPubMed
9.
go back to reference Ishibashi T, Tanaka K, Taniguchi Y. Disruption of iridial blood-aqueous barrier in experimental diabetic rats. Graefes Arch Clin Exp Ophthalmol. 1982;219(4):159–64.CrossRefPubMed Ishibashi T, Tanaka K, Taniguchi Y. Disruption of iridial blood-aqueous barrier in experimental diabetic rats. Graefes Arch Clin Exp Ophthalmol. 1982;219(4):159–64.CrossRefPubMed
10.
go back to reference Melo GB et al. Microbial profile and antibiotic susceptibility of culture-positive bacterial endophthalmitis. Eye (Lond), 2011. 25(3): p. 382-7; quiz 388. Melo GB et al. Microbial profile and antibiotic susceptibility of culture-positive bacterial endophthalmitis. Eye (Lond), 2011. 25(3): p. 382-7; quiz 388.
11.
go back to reference Scheen AJ, Esser N, Paquot N. Antidiabetic agents: potential anti-inflammatory activity beyond glucose control. Diabetes Metab. 2015;41(3):183–94.CrossRefPubMed Scheen AJ, Esser N, Paquot N. Antidiabetic agents: potential anti-inflammatory activity beyond glucose control. Diabetes Metab. 2015;41(3):183–94.CrossRefPubMed
12.
go back to reference Gilbert R, et al. Statins as anti-inflammatory agents: a potential therapeutic role in sight-threatening non-infectious uveitis. Porto Biomed J. 2017;2(2):33–9.CrossRefPubMedPubMedCentral Gilbert R, et al. Statins as anti-inflammatory agents: a potential therapeutic role in sight-threatening non-infectious uveitis. Porto Biomed J. 2017;2(2):33–9.CrossRefPubMedPubMedCentral
Metadata
Title
Acute uveitis caused by abnormal glucose and lipid metabolism: a case report
Authors
Zhaojing Bi
Yan Liang
Shujun Liu
Yuanbin Li
Publication date
01-12-2023
Publisher
BioMed Central
Keywords
Uveitis
Diabetes
Published in
BMC Ophthalmology / Issue 1/2023
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-023-02997-z

Other articles of this Issue 1/2023

BMC Ophthalmology 1/2023 Go to the issue